1. Home
  2. ELWT vs XLO Comparison

ELWT vs XLO Comparison

Compare ELWT & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELWT

Elauwit Connection Inc.

N/A

Current Price

$5.60

Market Cap

58.5M

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$7.82

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELWT
XLO
Founded
2002
2016
Country
United States
United States
Employees
34
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.5M
49.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ELWT
XLO
Price
$5.60
$7.82
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$12.00
$28.00
AVG Volume (30 Days)
24.8K
26.0K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
$28.81
N/A
Revenue Next Year
$70.70
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$4.11
$0.46
52 Week High
$9.72
$9.25

Technical Indicators

Market Signals
Indicator
ELWT
XLO
Relative Strength Index (RSI) 31.93 62.29
Support Level $5.61 $7.47
Resistance Level $7.36 $8.97
Average True Range (ATR) 0.68 0.48
MACD -0.14 0.05
Stochastic Oscillator 14.23 85.31

Price Performance

Historical Comparison
ELWT
XLO

About ELWT Elauwit Connection Inc.

Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: